A tough blow for a budding prospect.
Coleman Crow, the pitching prospect the New York Mets acquired from the Los Angeles Angels for Eduardo Escobar, has undergone Tommy John surgery, per MLB Pipeline.
While the date of the surgery wasn't specified, Crow is expected to be out until sometime in 2024.
The Mets acquired Crow and right-handed pitcher Landon Marceaux in exchange for Escobar back in late-June. When the Mets landed Crow, he was already on the injured list since April with elbow inflammation. Per The Athletic, the Mets were comfortable with Crow's medical reports when they acquired him.
Prior to being placed on the IL, Crow, 22, was having a strong season in the minor leagues. Across four starts in Double-A, Crow was 2-0 with a 1.88 ERA and 0.63 WHIP. He also had 31 strikeouts in 24 innings pitched. His final start came on April 26 when he allowed two runs in seven innings and struck out six batters.
Last season, the righty made 23 starts (24 games) in Double-A, posting a 9-3 record and a 4.85 ERA. He also struck out 128 batters in 128 innings.
MLB Pipeline ranked Crow as the No. 29 prospect in the Mets' farm system. However, he is not expected to arrive in the big-leagues until 2025.
More must-reads: